The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis.
We sought to determine the antiinflammatory properties of lymecycline in the long-term treatment of reactive arthritis (ReA). Quantitative assay of collagenase activity by densitometry after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Therapeutic levels of lymecycline do not directly inhibit the activity of human neutrophil interstitial collagenase, but can prevent the oxidative activation of latent human neutrophil collagenase. This non-antimicrobial, anticollagenolytic property of lymecycline may contribute to its therapeutic efficacy in the treatment of patients with ReA.